Evidence map›Paper›PMID 42170950›Full record

ArticleJournal of chemical information and modeling2026

Adaptive Disorder as the Hallmark of Nanobodies Antigen-Binding Loops.

Davide Bagordo, Gauthier Trèves, Mariangela Santorsola, Giorgio Colombo, Francesco Lescai

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Davide BagordoDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia27100, Italy.
Gauthier TrèvesDepartment of Chemistry, University of Pavia, Pavia27100, Italy.ORCID 0009-0007-3454-0880
Mariangela SantorsolaDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia27100, Italy.
Giorgio ColomboDepartment of Chemistry, University of Pavia, Pavia27100, Italy.ORCID 0000-0002-1318-668X
Francesco LescaiDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia27100, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanobodies are antigen-binding proteins of great interest as diagnostics and therapeutics. Accurate and fast characterization of their complementarity-determining regions (CDRs) is crucial to uncover the principles guiding their design. Yet, this task remains challenging, as random recombination and somatic mutations generate highly diverse CDR sequences that escape motif-based or structure-prediction approaches currently used to identify them. To overcome this hurdle, we employed two independent strategies that converged on the same conclusion. At the sequence level, we developed a deep learning model to identify nanobody CDRs directly from the primary sequence. At the structural level, we applied an energy decomposition method, revealing CDRs as residues highly uncoupled to the rest of the fold. Explainability analyses showed the network captured intrinsic CDR properties, which notably aligned with these energy values. CDRs emerge as fuzzy regions capable of adopting diverse conformational ensembles, from which a preferred state is selected upon antigen binding. This finding supports a model where chaos in both sequence and structure appears adaptive and disorder emerges as the hallmark of nanobody CDRs. This work aims to advance the definition of rules for the design of antigen binding regions, paving the way for the next-generation immune diagnostics and therapeutics.

Indexed as

AntigensComplementarity Determining RegionsSingle-Domain AntibodiesAmino Acid SequenceDeep LearningModels, MolecularProtein BindingProtein ConformationAntigensComplementarity Determining RegionsSingle-Domain Antibodies

Identifiers

PMID42170950
PMCPMC13250985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.